Transaction · 0002048593-26-000010

Saint Sean

Saint Sean, PRES, CEO, reported an open-market or private sale at Beta Bionics, Inc. involving 5641.000000 shares for an estimated $113258.87. Reported holdings after the transaction were 398429.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, CEO
BBNXBeta Bionics, Inc.
Filing timeSep 04
Trade dateSep 03, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$19.42
Pre-filing
1mo ago -25.0%1w ago +0.6%1d ago -0.1%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

BBNX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BBNX since 2026-09-04Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002048593-26-000010
Common Stock
Transaction date
Sep 03, 2026
Filed Sep 04, 2026, 09:19 PM · 1d delay
Shares
5.64k sh
$2.00k per share
Estimated value
-$11.3M
Computed from shares × price
Holdings after
398k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025.

  2. F2

    The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of…

Original filing · 0002048593-26-000010
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BBNX